CP-226,269 je lek koji deluje kao dopaminski agonist. On je selektivan za D4 podtip. CP-226,269 se koristi za istraživanje uloge D4 receptora u mozgu.[1][2]

CP-226,269
IUPAC ime
5-fluoro-2-[(4-piridin-2-ilpiperazin-1-il)metil]-1H-indol
Identifikatori
CAS broj220941-93-5 ДаY
ATC kodnone
PubChemCID 9796720
ChemSpider7972486 ДаY
ChEMBLCHEMBL77395
Hemijski podaci
FormulaC18H19FN4
Molarna masa310,368 g/mol
  • n4ccccc4N3CCN(CC3)Cc2cc1cc(F)ccc1n2
  • InChI=1S/C18H19FN4/c19-15-4-5-17-14(11-15)12-16(21-17)13-22-7-9-23(10-8-22)18-3-1-2-6-20-18/h1-6,11-12,21H,7-10,13H2 ДаY
  • Key:PQOIDBZLMJMYCD-UHFFFAOYSA-N ДаY

Reference

уреди
  1. ^ Sharma A, Kramer ML, Wick PF, Liu D, Chari S, Shim S, Tan W, Ouellette D, Nagata M, DuRand CJ, Kotb M, Deth RC (1999). „D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia”. Molecular Psychiatry. 4 (3): 235—46. PMID 10395213. doi:10.1038/sj.mp.4000522. 
  2. ^ Basso AM, Gallagher KB, Bratcher NA, Brioni JD, Moreland RB, Hsieh GC, Drescher K, Fox GB, Decker MW, Rueter LE (2005). „Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test”. Neuropsychopharmacology. 30 (7): 1257—68. PMID 15688083. doi:10.1038/sj.npp.1300677. 

Spoljašnje veze

уреди